Search research articles
Contact Us
Filters
Showing results (211-220 of 279) with videos related to
Page
of 28
Sort By:
Journal of Physical Activity & Health
|
November 17, 2016
Results From Denmark's 2016 Report Card on Physical Activity for Children and Youth
Lisbeth Runge Larsen, Jens Troelsen, Kasper Lund Kirkegaard, et al.
Frontiers in Cellular and Infection Microbiology
|
July 22, 2022
CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy
Stine Sofie Frank Lende, Marie Høst Pahus, Ida Monrad, et al.
Mediators of Inflammation
|
December 24, 2015
Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients
Ane Bjerg Christensen, Anders Dige, Johan Vad-Nielsen, et al.
Plant Methods
|
December 14, 2011
High Resolution Melt (HRM) analysis is an efficient tool to genotype EMS mutants in complex crop genomes
Seosamh Ó Lochlainn, Stephen Amoah, Neil S Graham, et al.
The Pediatric Infectious Disease Journal
|
October 4, 2018
Pediatric Candidemia Epidemiology and Morbidities: A Nationwide Cohort
Karen Rokkedal Lausch, Kia Hee Schultz Dungu, Michael Thude Callesen, et al.
Immunology
|
March 29, 2019
cAIMP administration in humanized mice induces a chimerization-level-dependent STING response
Anna H F Andersen, Rikke Olesen, Kasper L Jønsson, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
February 22, 2023
Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology
Jane Agergaard, Benjamin Yamin Ali Khan, Thomas Engell-Sørensen, et al.
Journal of Virology
|
July 31, 2015
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat
Rikke Olesen, Selena Vigano, Thomas A Rasmussen, et al.
The Lancet. HIV
|
October 2, 2015
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Thomas A Rasmussen, Martin Tolstrup, Christel R Brinkmann, et al.
Msphere
|
February 23, 2018
Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits <i>Ex Vivo</i> Lipopolysaccharide-Induced Inflammatory Responses
Christel Rothe Brinkmann, Jesper Falkesgaard Højen, Thomas Aagaard Rasmussen, et al.
Page
of 28
Search research articles
Search
Showing results (211-220 of 279) with videos related to
Sort By:
Page
of 28
Journal of Physical Activity & Health
|
November 17, 2016
Results From Denmark's 2016 Report Card on Physical Activity for Children and Youth
Lisbeth Runge Larsen, Jens Troelsen, Kasper Lund Kirkegaard, et al.
Frontiers in Cellular and Infection Microbiology
|
July 22, 2022
CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy
Stine Sofie Frank Lende, Marie Høst Pahus, Ida Monrad, et al.
Mediators of Inflammation
|
December 24, 2015
Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients
Ane Bjerg Christensen, Anders Dige, Johan Vad-Nielsen, et al.
Plant Methods
|
December 14, 2011
High Resolution Melt (HRM) analysis is an efficient tool to genotype EMS mutants in complex crop genomes
Seosamh Ó Lochlainn, Stephen Amoah, Neil S Graham, et al.
The Pediatric Infectious Disease Journal
|
October 4, 2018
Pediatric Candidemia Epidemiology and Morbidities: A Nationwide Cohort
Karen Rokkedal Lausch, Kia Hee Schultz Dungu, Michael Thude Callesen, et al.
Immunology
|
March 29, 2019
cAIMP administration in humanized mice induces a chimerization-level-dependent STING response
Anna H F Andersen, Rikke Olesen, Kasper L Jønsson, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
February 22, 2023
Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology
Jane Agergaard, Benjamin Yamin Ali Khan, Thomas Engell-Sørensen, et al.
Journal of Virology
|
July 31, 2015
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat
Rikke Olesen, Selena Vigano, Thomas A Rasmussen, et al.
The Lancet. HIV
|
October 2, 2015
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Thomas A Rasmussen, Martin Tolstrup, Christel R Brinkmann, et al.
Msphere
|
February 23, 2018
Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits <i>Ex Vivo</i> Lipopolysaccharide-Induced Inflammatory Responses
Christel Rothe Brinkmann, Jesper Falkesgaard Højen, Thomas Aagaard Rasmussen, et al.
Page
of 28